Bruker (BRKR) β†’ Stock, financial statements
Advertising

Bruker

93.86 USD +5.92 (+7.66%)
Mar 27 πŸ‡ΊπŸ‡Έ NASDAQ BRKR
Dividends News
Favorites
  • BRKR Ticker
  • πŸ‡ΊπŸ‡Έ NASDAQ Exchange
  • 6,870 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements β€” Bruker

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
2B 2.1B 1.9B 1.8B 1.6B
Cost Of Revenue
1B 1.1B 1M 950M 870M
Gross Profit
940M 1M 900M 810M 740M
Research and Development
200M 190M 170M 160M 150M
Selling General and Admin
470M 500M 440M 420M 390M
Operating Expense
1.7B 1.8B 1.6B 1.5B 1.4B
Operating Income
270M 310M 280M 230M 200M
Other Income Expense Net
0 0 0 0 0
EBIT
270M 310M 280M 230M 200M
Interest Income
11M 15M 11M 15M 13M
Pretax Income
230M 280M 240M 200M 180M
Income Tax
64M 82M 64M 120M 23M
Minority Interest
3.6M 800K 1.3M 1.7M 900K
Net Income
160M 200M 180M 79M 150M
Net Income Basic
160M 200M 180M 79M 150M
20 ← 16 2020 2019 2018 2017 2016
Current cash
730M 680M 320M 440M 500M
Short term investments
170M 170M 120M 110M 91M
Receivables
340M 360M 360M 320M 240M
Inventory
690M 580M 510M 490M 440M
Other current assets
170M 170M 120M 110M 91M
Current assets
1.9B 1.8B 1.3B 1.4B 1.3B
Long term investments
1.1B 980M 820M 590M 530M
Property plant equipment
400M 310M 270M 270M 240M
Goodwill
320M 290M 280M 170M 130M
Intangible assets
230M 230M 220M 82M 70M
Other assets
40M 17M 8.4M 14M 17M
Total assets
3B 2.8B 2.1B 1.9B 1.8B
Accounts payable
130M 120M 100M 91M 86M
Current long term debt
2.2M 500K 19M 0 20M
Other current liabilities
660M 530M 480M 430M 420M
Total current liabilities
790M 650M 600M 520M 520M
Long term debt
840M 810M 320M 420M 390M
Other liabilities
350M 280M 230M 250M 190M
Minority Interest
13M 31M 31M 8.1M 6.7M
Total Liabilities
2.1B 1.9B 1.2B 1.2B 1.1B
Common stock
150M 160M 160M 160M 160M
Retained earning
1.4B 1.3B 1.1B 940M 890M
Treasury stock
-670M -540M -400M -400M -250M
Capital surplus
β€’ β€’ β€’ β€’ β€’
Shareholder equity
960M 910M 900M 730M 690M
Net tangible assets
410M 380M 400M 470M 490M
20 ← 16 2020 2019 2018 2017 2016
Net Income
160M 200M 180M 79M 150M
Depreciation
80M 76M 65M 64M 54M
Changes in receivables
-27M 5M 38M 75M 9.2M
Changes in inventories
120M 68M 23M 46M 18M
Cash change
47M 360M -120M -61M 32M
Cash flow
330M 210M 240M 150M 130M
Capital expenditures
-97M -73M -49M -44M -37M
Investments
β€’ β€’ β€’ β€’ β€’
Investing activity other
β€’ β€’ β€’ β€’ β€’
Total investing cash flows
-190M -160M -120M -30M -22M
Dividends paid
β€’ β€’ β€’ β€’ β€’
Net borrowings
-53M -44M -96M -140M -180M
Other financing cash flows
β€’ β€’ β€’ β€’ β€’
Cash flow financing
-160M 300M -110M -160M -27M
Exchange rate effect
β€’ β€’ β€’ β€’ β€’

Development and production of scientific instruments, analytical and diagnostic solutions. It is divided into six areas:
* x-ray systems: element analyzers, spectrometers with energy and wavelength dispersions, and diffractometers;
* magnetic resonance systems (nuclear magnetic resonance spectrometers, electronic paramagnetic resonance, medical magnetic resonance tomographs);
* equipment for synchrotrons (x-ray mirrors, monochromators, protein analysis systems, x-ray microscopes), high-and low-temperature superconducting magnets, products for aviation and space technology;
* microanalysis systems for electron and ion beam microscopes, including x-ray spectrometers with energy dispersion, microfocus x-ray sources, and reflected electron diffraction systems.